Duck: Here Come The New Anti-Depressants
If there's one thing I admire about pharma companies, it's that they are always looking to build a better drug. OK, it's the only thing I admire about them. That said, here's a report on what we'll hear a lot more about in the next few years--the triple-uptake inhibitors. Unlike SSRIs, they will target the dopamine, serotonin and norepinephrine receptors. We'll see how these work, but I don't expect much improvement since anti-depressants that target two receptors haven't exactly set the world on fire.
I am really at the point where I begin to question if we haven't made all the advances we can on the meds side of the equation.
Posted by Philip Dawdy at March 6, 2006 12:02 AM
del.icio.us
Digg it
reddit
oh god, i hope we never get to the point of this is all there is. it's these meds or nothing. because of course most of these meds are not working. and so it makes it difficult for anyone to seek out other treatments like therapy, etc. when it's troubling enough on some days to simply get out of bed or go to work. i hope in my lifetime america gets a B+ and not a D.
of course in order for this to happen, people need to speak up and say, this is not good enough.
